Author:
Kano Kazuki,Yamada Takanobu,Yamamoto Kouji,Komori Keisuke,Watanabe Hayato,Hara Kentaro,Shimoda Yota,Maezawa Yukio,Fujikawa Hirohito,Aoyama Toru,Tamagawa Hiroshi,Yamamoto Naoto,Cho Haruhiko,Shiozawa Manabu,Yukawa Norio,Yoshikawa Takaki,Morinaga Soichiro,Rino Yasushi,Masuda Munetaka,Ogata Takashi,Oshima Takashi
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6): 394–424, 2018. PMID: 30207593. https://doi.org/10.3322/caac.21492.
2. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357:1810–20. 5.
3. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379: 315–21. 6.
4. Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage iii gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 2019;37(15):1296–304.
5. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11–20. 7.